Spontaneous Regression of Soft Tissue Sarcoma After Biopsy: Case Report and Review

Spontaneous regression of sarcoma is an exceedingly rare medical occurrence. Recent documentation has highlighted cases where soft tissue sarcomas regressed following a biopsy, a phenomenon that challenges standard expectations of tumor progression.

A case report published on May 16, 2019, in Case Rep Oncol detailed the experience of a 62-year-old male who presented with myxofibrosarcoma of the thigh. Following an open biopsy, the tumor underwent spontaneous regression.

The study was conducted by researchers from the National Defense Medical College in Tokorozawa, Japan, including Tsukasa Mizuno, Michiro Susa, Keisuke Horiuchi, Hideyuki Shimazaki, Kuniaki Nakanishi, and Kazuhiro Chiba.

Clinical Management and Outcomes

The medical team noted that treatment strategies for sarcomas that regress spontaneously are not well-documented in existing medical literature. Despite the regression observed after the biopsy, the patient in this case was treated with surgical resection.

The resection was successful, and the extent of the tumor was determined to guide the surgical process. This approach ensured the management of the condition despite the unusual behavior of the malignancy.

Medical Context and Research

The rarity of these events has led to further academic scrutiny. A systematic review of the literature and a case report published by Cureus have further examined the spontaneous regression of soft tissue sarcomas following biopsy procedures.

While the majority of soft tissue sarcomas require aggressive intervention—such as the wide local excision used for Alveolar Soft Part Sarcoma (ASPS) or embolization for infantile fibrosarcoma-related complications—spontaneous regression remains an outlier in oncology.

Because these instances are so infrequent, there is a lack of established guidance on how to manage patients whose tumors regress without primary oncological treatment. The 2019 report emphasizes that the lack of documented strategies makes each case a critical point of study for orthopedic surgeons and oncologists.